Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Boc-S-methyl-L-penicillamine dicyclohexylammonium salt | Boc-S-methyl-L-penicillamine dicyclohexylammonium salt is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Boc-L-Pen(Me)-OH DCHA; Boc-β,β-dimethyl-L-Cys(Me)-OH DCHA; N-tert-butoxycarbonyl-S-methyl-L-penicillamine dicyclohexylamine; Dicyclohexylamine (R)-2-((tert-butoxycarbonyl)amino)-3-methyl-3-(methylthio)butanoate; N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-3-(methylsulfanyl)-L-valine N-cyclohexylcyclohexanamine (1:1); L-Valine, N-[(1,1-dimethylethoxy)carbonyl]-3-(methylthio)-, compd. with N-cyclohexylcyclohexanamine (1:1). CAS No. 112898-23-4. Pack Sizes: 1mg;1g;10g. Product ID: BAT-007169. Molecular formula: C11H21NO4S.C12H23N. Mole weight: 444.68. Custom synthesis is available. Send your inquiries for more information. |  London |
| N-Phenyl-N-cyclohexyl-p-phenylenediamine | 1g Pack Size. Group: Amines, Building Blocks, Organics. Formula: C18H22N2. CAS No. 101-87-1. Prepack ID : 90018990-1g. Molecular Weight : 266.39. |  |
| N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine | N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine is a derivative of D-Penicillamine, which is a penicillin metabolite used in the treatment of Wilson's disease, Cystinuria, Scleroderma and arsenic poisoning. Group: Pharmaceutical. Alternative Names: Boc-S-4-Methylbenzyl-L-penicillamine dicyclohexylammonium salt; L-Valine, N-[(1,1-dimethylethoxy)carbonyl]-3-[[(4-methylphenyl)methyl]thio]-, compd. with N-cyclohexylcyclohexanamine (1:1); N-Cyclohexylcyclohexanaminium (2R)-3-methyl-3-[(4-methylbenzyl)sulfanyl]-2-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)butanoate; N-α-(t-Butoxycarbonyl)-S-(4-methylbenzyl)-L-penicillamine dicyclohexylammonium salt; Boc-L-Pen(pMeBzl)-OH.DCHA; Boc-β,β-dimethyl-L-Cys(pMeBzl)-OH.DCHA. CAS No. 198474-61-2. Pack Sizes: 1mg;1g;10g. Product ID: BAT-015032. Molecular formula: C18H27NO4S.C12H23N. Mole weight: 534.8. Custom synthesis is available. Send your inquiries for more information. | London |
| Bromhexine hydrochloride | Bromhexine is a mucolytic (expectorant) agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. In addition, bromhexine has antioxidant properties. Group: Pharmaceutical. Alternative Names: Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, hydrochloride (1:1); Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride; Toluene-α,2-diamine, 3,5-dibromo-Nα-cyclohexyl-Nα-methyl-, monohydrochloride; 2,4-Dibromo-6-[(cyclohexyl-methyl-amino)-methyl]-phenylamine hydrochloride; 2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine monohydrochloride; Auxit; Bisolvon; Bisolvon hydrochloride; Bromhexine chloride; Bromhexine monohydrochloride; Cyclohexylmethyl(2-amino-3,5-dibromobenzyl)ammonium chloride; N-Cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)ammonium chloride; N-Cyclohexyl-N-methyl-N-(2-amino-3,5-dibromobenzyl)ammonium chloride; Nα-Cyclohexyl-Nα-methyl-3,5-dibromotoluene-α,2-diamine hydrochloride; Ophtosol; Quentan. CAS No. 611-75-6. Pack Sizes: 1mg;1g;10g. Product ID: NP3716. Molecular formula: C14H20Br2N2.HCl. Mole weight: 412.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Bromhexine Related Compound 2 HCl | An impurity of Bromhexine, a mucolytic (expectorant) agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. Group: Pharmaceutical. Alternative Names: Bromhexine Related Compound 2 hydrochloride; 2-Amino-3-bromo-5-chloro-N-cyclohexyl-N-methylbenzenemethanamine. CAS No. 32193-43-4. Pack Sizes: 5 mg. Product ID: B2694-467763. Molecular formula: C14H21BrCl2N2. Mole weight: 368.14. Custom synthesis is available. Send your inquiries for more information. | London |
| Ciclopirox ethanolamine | Ciclopirox ethanolamine (Ciclopirox olamine, HOE 296) is a broad-spectrum antifungal agent working as an iron chelator. Uses: Antifungal agents. Group: Pharmaceutical. Alternative Names: Ciclopirox olamine; 41621-49-2; Ciclopirox ethanolamine; ciclopiroxolamine; Batrafen; Micoxolamina; Brumixol; Mycoster; Ciclopiroxolamin; Ciclochem; Dafnegin; Ciclopirox (olamine); HOE 296; Ciclopirox ethanolamine salt (1:1); HOE-296; UNII-50MD4SB4AP; EINECS 255-464-9; 50MD4SB4AP; NSC 336278; NSC-336278; DTXSID6045583; RV4104A; MFCD00078997; 6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt; Ciclobirox Olamine; 6-Cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one compound with 2-aminoethanol (1:1); MLS003170863; 2-aminoethanol; 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one. CAS No. 41621-49-2. Pack Sizes: 25 g. Product ID: B0084-068466. Molecular formula: C12H17NO2.C2H7NO. Mole weight: 268.35. Custom synthesis is available. Send your inquiries for more information. | London |
| PKC-Theta Inhibitor | PKC-theta inhibitor is a selective PKC-theta inhibitor with IC50 of 12 nM. Group: Pharmaceutical. Alternative Names: CHEMBL248183; N4-((4-(Aminomethyl)Cyclohexyl)Methyl)-5-Nitro-N2-(2-(Trifluoromethoxy)Benzyl)Pyrimidine-2,4-Diamine; VC-8650; SCHEMBL3953579. CAS No. 736048-65-0. Pack Sizes: 5 mg. Product ID: B2693-373030. Molecular formula: C20H25F3N6O3. Mole weight: 454.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Purmorphamine | Purmorphamine, under the IUPAC name 9-Cyclohexyl-N-[4-(4-morpholinyl)phenyl]-2-(1-naphthalenyloxy)-9H-purin-6-amine, is a cell-permeable 6,9-trisubstituted purine which directly binds and activates Smoothened (in HEK293T cell:IC50= ~ 1.5 μM ).So it has been shown to activate the Hedgehog (Hh) signaling pathway which is important for regulating embryonic patterning, stem cell renewal, and tissue regeneration. In vitro: An activator of the hedgehog (Hh) signaling pathway by directly binds and activates Smoothened (in HEK293T cell:IC50= ~ 1.5 μM ). In vivo: Purmorphamine up-regulates ALP expression in human mesenchymal stem cell-based constructs on rats. Uses: Directly binds and activates smoothened (in hek293t cell:ic50= ~ 1.5 μm ); an activator of the hedgehog (hh) signaling pathway; an inducer of osteoblast differentiation (ec50= 1 μm). Group: Pharmaceutical. Alternative Names: 9-cyclohexyl-N-(4-morpholin-4-ylphenyl)-2-naphthalen-1-yloxypurin-6-amine; purmorphamine; Purmorphamine; 483367-10-8; 2-(1-Naphthoxy)-6-(4-morpholinoanilino)-9-cyclohexylpurine; UNII-PB12M2F8KY; Shh Signaling Antagonist VI; PB12M2F8KY; CHEMBL1221984; CHEBI:63053; C31H32N6O2; IN1132; 9-cyclohexyl-N-[4-(morpholin-4-yl)phenyl]-2-(naphthalen-1-yloxy)-9H-purin-6-amine; 9-cyclohexyl-N-(4-morpholin-4-ylp. CAS No. 483367-10-8. Pack Sizes: 100 mg. Product ID: B0084-211514. Molecular formula: C31H32N6O2. Mole weight: 520.6. Custom synthesis is avaiĀ | London |
| 2-(2-hydroxy-4,5-dimethoxybenzamido)thiazole-4-carboxylic acid | An impurity of Acotiamide, a drug for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. Group: Pharmaceutical. Alternative Names: N-[[1-[(4-aminocyclohexyl)methyl]pyrrolidin-2-yl]methyl]-N-[(E)-3-(2,4-difluorophenyl)-2-methylprop-2-enyl]-3,4-dimethoxybenzamide; tert-butyl N-[4-[[2-[[[(E)-3-(2,4-difluorophenyl)-2-methylprop-2-enyl]-(3,4-dimethoxybenzoyl)amino]methyl]pyrrolidin-1-yl]methyl]cyclohexyl]carbamate. CAS No. 1809272-85-2. Pack Sizes: 100 mg. Product ID: B0228-284900. Molecular formula: C13H12N2O6S. Mole weight: 324.31. Custom synthesis is available. Send your inquiries for more information. | London |
| A-893 | A-893 is an inhibitor of SMYD2, which is a lysine methyltransferase. The co-crystal structure reveals the origin of enhanced potency, and effective inhibition of p53K370 methylation in a lung carcinoma (A549) cell line. Group: Pharmaceutical. Alternative Names: A893; A 893; (R)-N-cyclohexyl-3-((3,4-dichlorophenethyl)amino)-N-(2-((2-hydroxy-2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl)amino)ethyl)propanamide; Propanamide, N-cyclohexyl-3-[[2-(3,4-dichlorophenyl)ethyl]amino]-N-[2-[[(2R)-2-(3,4-dihydro-3-oxo-2H-1,4-benzoxazin-8-yl)-2-hydroxyethyl]amino]ethyl]-; N-Cyclohexyl-N3-[2-(3,4-dichlorophenyl)ethyl]-N-(2-{[(2R)-2-hydroxy-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-8-yl)ethyl]amino}ethyl)-β-alaninamide. CAS No. 1868232-32-9. Pack Sizes: 1mg;1g;10g. Product ID: 1868232-32-9. Molecular formula: C29H38Cl2N4O4. Mole weight: 577.54. Custom synthesis is available. Send your inquiries for more information. | London |
| AS 1842856 | AS 1842856 is a potent and selective inhibitor of Forkhead box protein O1 transcription factor (FoxO1; IC50 = 33 nM). AS 1842856 reduces glucose production in dose manner via the inhibition of glucose-6 phosphatase and phosphoenolpyruvate carboxykinase mRNA levels in a rat hepatic cell line. AS 1842856 is promisingly to be a therapy of type 2 diabetes mellitus and obesity. Uses: Potential treatment of type 2 diabetes mellitus and obesity. Group: Pharmaceutical. Alternative Names: AS1842856; AS-1842856; AS 1842856. 5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. CAS No. 836620-48-5. Pack Sizes: 200 mg. Product ID: B1370-054875. Molecular formula: C18H22FN3O3. Mole weight: 347.38. Custom synthesis is available. Send your inquiries for more information. | London |
| CUDA | CUDA is an inhibitor of soluble epoxide hydrolase (sEH) which catalyzes the conversion of EETs to the corresponding dihydroxy eicosatrienoic acids (DiHETrEs; DHETs) thereby diminishing their activity with IC50 values of 11.1 nM and 112 nM for the mouse and human enzymes, respectively. Group: Pharmaceutical. Alternative Names: 12-[[(cyclohexylamino)carbonyl]amino]-dodecanoic acid. CAS No. 479413-68-8. Pack Sizes: 25 mg. Product ID: B2693-251168. Molecular formula: C19H36N2O3. Mole weight: 340.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Cytidine(CME) | (2R,5S)-(1R,2S,5R)-2-Isopropyl-5-methylcyclohexyl 5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate is an impurity of Lamivudine, which is a potent nucleoside reverse transcriptase inhibitor and antiviral agent used to treat chronic hepatitis B. Group: Pharmaceutical. Alternative Names: 1,3-Oxathiolane-2-carboxylic acid, 5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, (2R,5S)-; (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl (2R,5S)-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate; 1,3-Oxathiolane-2-carboxylic acid, 5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-, 5-methyl-2-(1-methylethyl)cyclohexyl ester, [1R-[1α(2R*,5S*),2β,5α]]-; (2R,5S)-5-(4-Amino-2-oxo-1,2-dihydro-1-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl ester; (2R,5S)-L-Menthol-5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylate; Lamivudine Impurity 17. CAS No. 147027-10-9. Pack Sizes: 1mg;1g;10g. Product ID: NP3435. Molecular formula: C18H27N3O4S. Mole weight: 381.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban impurity G tosylate | An impurity of Edoxaban, an oral anticoagulant drug and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide 4-methylbenzenesulfonate; Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, compd. with 4-methylbenzenesulfonate (1:1); N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide tosylate. CAS No. 2852734-47-3. Pack Sizes: 2 mg. Product ID: B1370-448091. Molecular formula: C31H38ClN7O7S2. Mole weight: 720.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban impurity H | Edoxaban Impurity. Group: Pharmaceutical. Alternative Names: N-(5-Chloropyridin-2-yl)-N'-[(1S,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide. CAS No. 1255529-28-2. Pack Sizes: 2.5 mg. Product ID: B2694-470647. Molecular formula: C24H30ClN7O4S. Mole weight: 548.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban impurity I | The enantiomer of Edoxaban, Edoxaban Impurity. Group: Pharmaceutical. Alternative Names: N-(5-Chloropyridin-2-yl)-N'-[(1R,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide. CAS No. 1255529-23-7. Pack Sizes: 2.5 mg. Product ID: B2694-470648. Molecular formula: C24H30ClN7O4S. Mole weight: 548.07. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban N-Oxide | An impurity of Edoxaban, which is an oral anticoagulant drug and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: (5S)-5-Oxide Edoxaban; 2-(((1R,2S,5S)-2-(2-((5-Chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-Oxide. CAS No. 2244103-96-4. Pack Sizes: 50 mg. Product ID: B1370-377836. Molecular formula: C24H30ClN7O5S. Mole weight: 564.06. Custom synthesis is available. Send your inquiries for more information. | London |
| Edoxaban Tosylate Hydrate | In human plasma, Edoxaban doubles prothrombin time and activates partial thromboplastin time at 0.256 and 0.508 μM, respectively. Group: Pharmaceutical. Alternative Names: N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-Toluenesulfonate hydrate; N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide mono(p-toluenesulfonate) hydrate; Edoxaban p-toluenesulfonate monohydrate. CAS No. 1229194-11-9. Pack Sizes: 1 g. Product ID: B0084-463378. Molecular formula: C24H30ClN7O4S.C7H8O3S.H2O. Mole weight: 738.27. Custom synthesis is available. Send your inquiries for more information. | London |
| Enalapril EP Impurity G | An impurity of Enalapril. Enalapril is an angiotensin-converting-enzyme inhibitor used in the treatment of hypertension, diabetic nephropathy, and some types of chronic heart failure. Group: Pharmaceutical. Alternative Names: (2S)-2-[[(1S)-3-Cyclohexyl-1-(ethoxycarbonyl)propyl]amino] propanoic acid. CAS No. 460720-14-3. Pack Sizes: 100 mg. Product ID: B2694-470982. Molecular formula: C15H27NO4. Mole weight: 285.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Glipizide | Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. Glipizide is used to treat high blood sugar levels caused by a type of diabetes mellitus called type 2 diabetes. Uses: Hypoglycemic agents. Group: Pharmaceutical. Alternative Names: 2-Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-; N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide; Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-; Urea, 1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]-; Aldiab; CP 28720; Digrin; Dipazide; Glibenese; Glibetin; Glican; Glidiab; Glipid; Glipizid; Gluco-Rite; Glucolip; Glucotrol; Glucotrol Xl; Glucozide; Glupitel; Glupizide; Glyde; Glydiazinamide; Glynase; K 4024; Melizide; Mindiab; Minidab; Minidiab; Minodiab; N-(4-[β-(5-Methylpyrazine-2-carboxamido)ethyl]benzenesulfonyl)-N'-cyclohexylurea; Napizide; Ozidia; Samarium(III) ionophore I; Semiglynase; Sucrazide; TK 1320. CAS No. 29094-61-9. Pack Sizes: 50 g. Product ID: B2692-089502. Molecular formula: C21H27N5O4S. Mole weight: 445.54. Custom synthesis is available. Send your inquiries for more information. | London |
| ISRIB | ISRIB is a symmetric bis-glycolamide that inhibits integrated stress response (ISR). In wild-type mice studies has shown that it improved memory by efficiently reversing the effects of eIF2α phosphorylation, which has brought expectation that inhibition of PERK signaling may have the potential to ameliorate Alzheimer's disease. In a present study ISRIB demonstrated to attenuate amyloid b-induced neuronal cell death although the pharmacological mechanisms of this action have not yet been elucidated. Group: Pharmaceutical. Alternative Names: 2-(4-chlorophenoxy)-N-[4-[[2-(4-chlorophenoxy)acetyl]amino]cyclohexyl]acetamide; 2-(4-chlorophenoxy)-N-(4-(2-(4-chlorophenoxy)acetamido)cyclohexyl)acetamide; ISRIB compound; trans-ISRIB. CAS No. 1597403-47-8. Pack Sizes: 250 mg. Product ID: BAT-010737. Molecular formula: C22H24Cl2N2O4. Mole weight: 451.34. Custom synthesis is available. Send your inquiries for more information. | London |
| Lisinopril Impurity F | Lisinopril Impurity F is an impurity of Lisinopril, a medication of the angiotensin-converting enzyme inhibitor class that is used to treat high blood pressure. Group: Pharmaceutical. Alternative Names: Lisinopril Cyclohexyl Analogue; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid. CAS No. 1132650-67-9. Pack Sizes: 10 mg. Product ID: B2694-262437. Molecular formula: C21H37N3O5. Mole weight: 411.54. Custom synthesis is available. Send your inquiries for more information. | London |
| N1-((1S,2R,4S)-2-amino-4-(dimethylcarbamoyl)cyclohexyl)-N2-(5-chloropyridin-2-yl)oxalamide | An impurity of Edoxaban, which is an oral anticoagulant drug and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: Ethanediamide, N-[(1S,2R,4S)-2-amino-4-[(dimethylamino)carbonyl]cyclohexyl]-N'-(5-chloro-2-pyridinyl); Edoxaban Impurity I. CAS No. 480452-37-7. Pack Sizes: 100 mg. Product ID: B1370-377825. Molecular formula: C16H22ClN5O3. Mole weight: 367.83. Custom synthesis is available. Send your inquiries for more information. | London |
| N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide | An impurity of Edoxaban, a direct factor Xa inhibitor used as an anticoagulant. Group: Pharmaceutical. Alternative Names: Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1R,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-; N1-(5-Chloro-2-pyridinyl)-N2-[(1R,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide; N-(5-Chloropyridin-2-yl)-N'-[(1R,2R,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide; N1-(5-Chloropyridin-2-yl)-N2-((1R,2R,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide; Edoxaban (1R,2R,4R) Isomer; Edoxaban (RRR)-Isomer; Edoxaban Impurity 25. CAS No. 1255529-24-8. Pack Sizes: 10 mg. Product ID: B2694-480568. Molecular formula: C24H30ClN7O4S. Mole weight: 548.06. Custom synthesis is available. Send your inquiries for more information. | London |
| N-Desmethyl Edoxaban Hydrochloride | N-Desmethyl Edoxaban Hydrochloride is an impurity of Edoxaban. Edoxaban is an anticoagulant medication and a direct factor Xa inhibitor. Group: Pharmaceutical. Alternative Names: Edoxaban M6; N1-(5-Chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide Hydrochloride. CAS No. 480449-52-3. Pack Sizes: 10 mg. Product ID: B1370-099170. Molecular formula: C23H29Cl2N7O4S. Mole weight: 570.49. Custom synthesis is available. Send your inquiries for more information. | London |
| N-Succinimidyl 6-[[4-(maleimidomethyl)cyclohexyl]carboxamido] caproate | N-Succinimidyl 6-[[4-(maleimidomethyl)cyclohexyl]carboxamido] caproate. Uses: A sulfhydryl and amino reactive heterobifunctional protein crosslinking reagent. Group: Pharmaceutical. Alternative Names: 6-[[[4-[(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)methyl]cyclohexyl]carbonyl]amino]hexanoic Acid 2,5-Dioxo-1-pyrrolidinyl Ester; LC-SMCC. CAS No. 125559-00-4. Pack Sizes: 100 mg. Product ID: B1370-121728. Molecular formula: C22H29N3O7. Mole weight: 447.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Oclacitinib maleate | Oclacitinib maleate was the first selective Janus kinase (JAK) inhibitor to be developed for dogs. Oclacitinib is most potent at inhibiting JAK1 (IC50=10 nM). Group: Pharmaceutical. Alternative Names: Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, trans-, (2Z)-2-butenedioate (1:x); Apoquel; Oclacitinib maleate (1:x); PF 03394197-11; trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide maleate (1:x); N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate. CAS No. 1208319-27-0. Pack Sizes: 10 g. Product ID: B1370-007675. Molecular formula: C15H23N5O2S.xC4H4O4. Mole weight: 337.44 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| Oclacitinib monomaleate | Oclacitinib, also called as PF-03394197, is a novel inhibitor of JAK family members (IC50 = 10 - 99 nM) and JAK1-dependent cytokines involved in allergy, inflammation, and pruritus (IC50 = 36 - 249 nM), without affecting a panel of 38 non-JAK kinases. It could reduce pruritus and associated inflammatory skin lesions in dogs with AD. Group: Pharmaceutical. Alternative Names: Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, trans-, (2Z)-2-butenedioate (1:1); trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide maleate (1:1); N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide monomaleate. CAS No. 1640292-55-2. Pack Sizes: 50 mg. Product ID: B2693-008142. Molecular formula: C15H23N5O2S.C4H4O4. Mole weight: 453.51. Custom synthesis is available. Send your inquiries for more information. | London |
| OTSSP167 hydrochloride | OTSSP167 is a potent inhibitor of Maternal embryonic leucine zipper kinase (MELK) which regulates neural stem cell selfrenewal through control of the cell cycle. Group: Pharmaceutical. Alternative Names: 4-[7-acetyl-8-[[4-[(dimethylamino)methyl]cyclohexyl]amino]-1H-1,5-naphthyridin-2-ylidene]-2,6-dichlorocyclohexa-2,5-dien-1-one hydrochloride; OTSSP167 (hydrochloride); UNII-65P731R507; 65P731R507; OTSSP167 HCl; OTS-167 monohydrochloride; HY-15512A; AKOS025117447. CAS No. 1431698-10-0. Pack Sizes: 50 mg. Product ID: B0084-474572. Molecular formula: C25H29Cl3N4O2. Mole weight: 523.9. Custom synthesis is available. Send your inquiries for more information. | London |
| Oxybutynin EP Impurity E | Oxybutynin EP Impurity E is an impurity of oxybutynin, which is an inhibitor of proliferation and supresses gene expression in bladder smooth muscle cells. Group: Pharmaceutical. Alternative Names: N-Desethyl-N-propyl Oxybutynin; 4-(Ethyl(propyl)amino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate; α-Cyclohexyl-α-hydroxybenzeneacetic Acid 4-(Ethylpropylamino)-2-butyn-1-yl Ester; Ethylpropyl Analog of Oxybutynin Chloride. CAS No. 1215677-72-7. Pack Sizes: 10 mg. Product ID: B1370-246494. Molecular formula: C23H33NO3. Mole weight: 371.51. Custom synthesis is available. Send your inquiries for more information. | London |
| PF-04691502 | PF-04691502 is an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity. It inhibits both PI3K and mTOR kinases, which may result in apoptosis and growth inhibition of cancer cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to chemotherapy and radiotherapy. mTOR, a serine/threonine kinase downstream of PI3K, may also be activated independent of PI3K. Group: Pharmaceutical. Alternative Names: PF04691502; PF 04691502; PF-04691502; PF4691502; PF 4691502; PF-4691502; 2-amino-8-((1R,4R)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one. CAS No. 1013101-36-4. Pack Sizes: 50 mg. Product ID: B0084-456382. Molecular formula: C22H27N5O4. Mole weight: 425.489. Custom synthesis is available. Send your inquiries for more information. | London |
| PF-4136309 | PF-4136309 is a potent, selective, and orally bioavailable antagonist of CCR2, a chemokine receptor of the super family of seven-transmembrane G-protein-coupled receptors (GPCRs). Group: Pharmaceutical. Alternative Names: (S)-N-(2-(3-((4-hydroxy-4-(5-(pyrimidin-2-yl)pyridin-2-yl)cyclohexyl)amino)pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide; PF4136309; PF 4136309; PF04136309; PF-04136309; INCB8761; INCB 8761; INCB-8761. CAS No. 1341224-83-6. Pack Sizes: 100 mg. Product ID: B2693-457930. Molecular formula: C29H31F3N6O3. Mole weight: 568.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Quasar 670 CE Phosphoramidite | Quasar 670 dyes are cyanine derivatives of Cyanine 5. Cyanine dyes are a popular oligonucleotide modification and are commonly used for imaging, flow cytometry, and genomic applications. Group: Pharmaceutical. Alternative Names: 3H-Indolium, 2-[5-[1-[6-[[trans-4-[[[bis(1-methylethyl)amino](2-cyanoethyl)phosphino]oxy]cyclohexyl]amino]-6-oxohexyl]-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene]-1,3-pentadien-1-yl]-1,3,3-trimethyl-, hexafluorophosphate(1-) (1:1). CAS No. 1032678-33-3. Pack Sizes: 250 mg. Product ID: R10-0017. Molecular formula: C47H67F6N5O2P2. Mole weight: 910.02. Custom synthesis is available. Send your inquiries for more information. | London |
| SH-4-54 | SH-4-54 is a potent STAT inhibitor with KD values of 300 nM and 464 nM for STAT3 and STAT5, respectively. It potently kills glioblastoma brain cancer stem cells (BTSCs). Group: Pharmaceutical. Alternative Names: 4-[(4-cyclohexylphenyl)methyl-[2-[methyl-(2,3,4,5,6-pentafluorophenyl)sulfonylamino]acetyl]amino]benzoic acid. CAS No. 1456632-40-8. Pack Sizes: 100 mg. Product ID: B0084-463434. Molecular formula: C29H27F5N2O5S. Mole weight: 610.59. Custom synthesis is available. Send your inquiries for more information. | London |
| Telaprevir-[d4] | Labelled Telaprevir. VX-950 is a potent, selective, peptidomimetic inhibitor of the hepatitis C virus (HCV) NS3-4A serine protease, and it demonstrated excellent antiviral activity both in genotype 1b HCV replicon cells (50% inhibitory concentration [IC50] = 354 nM) and in human fetal hepatocytes infected with genotype 1a HCV-positive patient sera (IC50 = 280 nM). VX-950 forms a covalent but reversible complex with the genotype 1a HCV NS3-4A protease in a slow-on, slow-off process with a steady-state inhibition constant (K(I)*) of 7 nM. Dissociation of the covalent enzyme-inhibitor complex of VX-950 and genotype 1a HCV protease has a half-life of almost an hour. A >4-log10 reduction in the HCV RNA levels was observed after a 2-week incubation of replicon cells with VX-950, with no rebound of viral RNA observed after withdrawal of the inhibitor. In several animal species, VX-950 exhibits a favorable pharmacokinetic profile with high exposure in the liver. In a recently developed HCV protease mouse model, VX-950 showed excellent inhibition of HCV NS3-4A protease activity in the liver. Group: Pharmaceutical. Alternative Names: (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1S)-1-[2-[(cyclopropyl-d4)amino]-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide; LY 570310-d4; MP 424-d4; VRT 111950-d4; VX 950-d4. Pack Sizes: 50 mg. Product ID: BLP-006018. Molecular formula: C36H49D4N7O6 | London |
| UNC 3230 | UNC 3230 is a potent and selective PIP5K1C inhibitor (IC50 = 41 nM), displaying selectivity for PIP5K1C over PIP5K1A, the PI 3-kinase family and a panel of other kinases. UNC 3230 decreases PIP2 levels and LPA-induced calcium signaling in dorsal root ganglia (DRG) neurons in vitro. UNC 3230 exhibits antinociceptive effects in mouse models of chronic pain. Group: Pharmaceutical. Alternative Names: UNC3230; UNC-3230; UNC 3230; 5-[(Cyclohexylcarbonyl)amino]-2-(phenylamino)-thiazolecarboxamide. CAS No. 1031602-63-7. Pack Sizes: 100 mg. Product ID: B2693-170513. Molecular formula: C17H20N4O2S. Mole weight: 344.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Validamycin B | Validamycin B is an impurity of Validamycin that is resistant to rice sheath blight disease and Pellicularia sasakii. Group: Pharmaceutical. Alternative Names: Antibiotic T-7545-B; Val-B; (1R,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside; 1,5-Dideoxy-4-O-β-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol. CAS No. 102583-47-1. Pack Sizes: 1mg;1g;10g. Product ID: BBF-03434. Molecular formula: C20H35NO14. Mole weight: 513.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Validamycin C | An impurity of Validamycin. Validamycin is an antibiotic and fungicide. Group: Pharmaceutical. Alternative Names: BRN 4835203; (3-{[4-(hexopyranosyloxy)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]amino}-4,5,6-trihydroxycyclohex-1-en-1-yl)methyl hexopyranoside; 2-(hydroxymethyl)-6-[[3-[[5-(hydroxymethyl)-4-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2,3-bis(oxidanyl)cyclohexyl]amino]-4,5,6-tris(oxidanyl)cyclohexen-1-yl]methoxy]oxane-3,4,5-triol. CAS No. 12650-70-3. Pack Sizes: 1mg;1g;10g. Product ID: BBF-03435. Molecular formula: C26H45NO18. Mole weight: 659.63. Custom synthesis is available. Send your inquiries for more information. | London |
| Ximelagatran | Ximelagatran, an ester prodrug of melagatran, with anticoagulant effect, is the first member of direct thrombin inhibitors that can be taken orally. Uses: An orally active direct thrombin inhibitor; prodrug of melagatran. antithrombotic. Group: Pharmaceutical. Alternative Names: H 376-95; H 376/95; H 37695; H-37695; H37695; N-[(1R)-1-Cyclohexyl-2-[(2S)-2-[[[[4-[(hydroxyamino)iminomethyl]phenyl]methyl]amino]carbonyl]-1-azetidinyl]-2-oxoethyl]glycine Ethyl Ester; Exanta; H 376/95. CAS No. 192939-46-1. Pack Sizes: 5 mg. Product ID: B0084-264384. Molecular formula: C24H35N5O5. Mole weight: 473.57. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
